GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 195 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $323,465,000 | +112.1% | 4,749,863 | -0.5% | 0.01% | +120.0% |
| Q2 2022 | $152,476,000 | -16.7% | 4,772,391 | -9.7% | 0.01% | 0.0% |
| Q1 2022 | $183,056,000 | +16.8% | 5,284,511 | -1.3% | 0.01% | +25.0% |
| Q4 2021 | $156,683,000 | +6.6% | 5,353,056 | -7.2% | 0.00% | 0.0% |
| Q3 2021 | $147,051,000 | -27.2% | 5,771,215 | +0.0% | 0.00% | -33.3% |
| Q2 2021 | $202,076,000 | +18.3% | 5,770,232 | +37.6% | 0.01% | +20.0% |
| Q1 2021 | $170,834,000 | +7.1% | 4,192,229 | +13.8% | 0.01% | 0.0% |
| Q4 2020 | $159,522,000 | -12.8% | 3,683,260 | +11.1% | 0.01% | -28.6% |
| Q3 2020 | $182,844,000 | -19.5% | 3,315,985 | -7.9% | 0.01% | -22.2% |
| Q2 2020 | $227,272,000 | -6.9% | 3,600,035 | -24.6% | 0.01% | -25.0% |
| Q1 2020 | $244,053,000 | -36.8% | 4,776,920 | -1.6% | 0.01% | -20.0% |
| Q4 2019 | $385,938,000 | +60.1% | 4,855,173 | -2.3% | 0.02% | +50.0% |
| Q3 2019 | $241,088,000 | +2.2% | 4,968,843 | +10.8% | 0.01% | 0.0% |
| Q2 2019 | $235,792,000 | +4.2% | 4,482,728 | +4.8% | 0.01% | 0.0% |
| Q1 2019 | $226,379,000 | +30.5% | 4,276,943 | +1.2% | 0.01% | +11.1% |
| Q4 2018 | $173,492,000 | +9.1% | 4,226,345 | +1.0% | 0.01% | +28.6% |
| Q3 2018 | $159,079,000 | -15.0% | 4,186,269 | +1.1% | 0.01% | -22.2% |
| Q2 2018 | $187,252,000 | +19.5% | 4,142,762 | +27.7% | 0.01% | +28.6% |
| Q1 2018 | $156,713,000 | +20.0% | 3,244,600 | -2.3% | 0.01% | +16.7% |
| Q4 2017 | $130,636,000 | +19.3% | 3,319,882 | -5.9% | 0.01% | 0.0% |
| Q3 2017 | $109,522,000 | +17.6% | 3,527,308 | +3.6% | 0.01% | +20.0% |
| Q2 2017 | $93,114,000 | -3.5% | 3,404,538 | +30.0% | 0.01% | 0.0% |
| Q1 2017 | $96,503,000 | +12084.7% | 2,618,847 | +4675.5% | 0.01% | +400.0% |
| Q4 2016 | $792,000 | -31.0% | 54,839 | +10.3% | 0.00% | -50.0% |
| Q3 2016 | $1,147,000 | +41.3% | 49,739 | +1.6% | 0.00% | +100.0% |
| Q2 2016 | $812,000 | +13433.3% | 48,964 | +12617.9% | 0.00% | – |
| Q1 2016 | $6,000 | -79.3% | 385 | -57.2% | 0.00% | – |
| Q4 2015 | $29,000 | -97.8% | 900 | -97.2% | 0.00% | -100.0% |
| Q3 2015 | $1,336,000 | – | 31,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 595,473 | $25,790,000 | 4.19% |
| Grace Capital | 131,549 | $5,697,000 | 3.60% |
| Fernwood Investment Management, LLC | 201,657 | $8,734,000 | 3.44% |
| Fairmount Funds Management LLC | 215,000 | $9,312,000 | 3.33% |
| Arctis Global LLC | 293,700 | $12,720,000 | 2.74% |
| Perceptive Advisors | 5,674,711 | $245,771,000 | 2.64% |
| ArchPoint Investors | 217,510 | $9,420,000 | 2.61% |
| Alerce Investment Management, L.P. | 126,270 | $5,469,000 | 2.15% |
| Profit Investment Management, LLC | 42,196 | $1,826,000 | 1.17% |
| Affinity Asset Advisors, LLC | 50,000 | $2,166,000 | 1.15% |